GLP-1 constipation: why your gut slowed down and what actually helps

The estimated medication curve across a weekly cycle, with the slower middle marked

Quick answer

Constipation is one of the most common side effects of GLP-1 medications, reported by 24% of people taking semaglutide 2.4 mg in the trials behind the Wegovy label, against 11% on placebo. It happens because the drug slows how fast food moves through you, and it is usually worst in the first weeks and after each dose increase.

What the research shows

The reliable numbers sit in the FDA prescribing information, where every count has a placebo group next to it. Constipation runs several times higher on the drug than on placebo, and higher at the weight management doses.

The labels also say when it clusters. Wegovy reports these reactions were most frequently reported during dosage escalation, and Zepbound says most gastrointestinal events occurred during escalation and decreased over time.

A small 2025 case series in ACG Case Reports Journal sent motility capsules through 10 patients on GLP-1 receptor agonists. Most of them had delayed gastric emptying, and a smaller share had slow transit through the colon and through the whole gut. Ten patients settle nothing on their own, but the slowdown is clearly not only in the stomach.

At the rare end, all three labels carry the same postmarketing entries: ileus, intestinal obstruction, severe constipation including fecal impaction. Those reports are voluntary, so no frequency can be attached to them.

Wegovy (semaglutide 2.4 mg): constipation in 24% versus 11% on placebo.
Zepbound (tirzepatide): 17% at 5 mg, 14% at 10 mg, 11% at 15 mg, versus 5% on placebo.
Ozempic (semaglutide, diabetes doses): 5% at 0.5 mg and 3.1% at 1 mg, versus 1.5% on placebo.

Why it happens and when to expect it

The Ozempic label says the drug causes a delay of gastric emptying. Zepbound says the delay is largest after the first dose and diminishes over time. Food sits longer, moves slower, and the longer stool spends in the colon the more water is pulled out of it. Drier stool is harder to pass.

There is a second cause that is not the drug: you are eating much less. Less food is less bulk and less fiber, and appetite loss drags your fluid intake down with it.

Then there is the dose cycle. On a weekly injection your level is not flat. Semaglutide has a published half-life of about 7 days and tirzepatide about 5, so each shot is still substantially present when the next lands. Levels climb from dose to dose over the first weeks, which is why the first month and every step up are where symptoms bunch together.

Where inside your week the hard days fall has no published rule. Some describe the tightest stretch right after the shot, others the end of the week, and only your own record answers it. On a daily oral there is no weekly rise and fall at all.

One piece of good news: a 2024 review in The Journal of Clinical Endocrinology and Metabolism reports that with sustained exposure the brake on gastric emptying weakens, though some slowing stays. The early weeks are usually the hardest part.

What actually helps

None of this is dose advice. We will never tell you to skip, split or delay a dose. That belongs to your prescriber.

Fluid before fiber. Adding fiber to a slow, dry gut without water first usually makes it worse.
Then add fiber slowly, from food. MedlinePlus points to fruits, vegetables and grains high in fiber.
Walk after you eat. Exercise sits on the MedlinePlus prevention list.
Go when you feel the urge. Waiting is how a slow week becomes a stuck one.
Eat smaller meals, because your stomach empties slower than it used to.
Ask a pharmacist before buying anything off the shelf. Bulk fiber, stool softeners and osmotic laxatives are not interchangeable, and MedlinePlus says to use laxatives only as directed by your provider.
Check the rest of your medicine cabinet. Iron, opioids, some antidepressants and some antacids slow the gut on their own.
Write it down. You cannot see a pattern you never recorded.

When to call your prescriber

Most GLP-1 constipation is uncomfortable and boring rather than dangerous. There is a line, though, and knowing where it sits is what lets you stop scrolling forums at 3am.

Read the red flags as a combination. Several days without a bowel movement, alone, is unpleasant. Several days without one plus a distended belly plus worsening pain is a different situation. Not passing gas at all is the detail that changes the picture fastest, and the one to say out loud when you call. Blood in the stool is a call, always.

The list below is the MedlinePlus page on intestinal obstruction, in plain words. A less urgent call is still worth making for constipation that has not budged after a few weeks, or that returns hard at every dose increase.

You cannot pass stool or gas.
You have a swollen abdomen that does not go away.
You keep vomiting.
You have unexplained abdominal pain that does not go away.

How Setva helps you see it coming

Setva is an iPhone app for people on GLP-1 treatment. On this symptom it does one narrow thing well: it puts what you felt and where you are in the dose cycle on the same picture.

Logging is a tap, with an intensity, on the day it happens. After a few weeks those taps line up against the day of your cycle. If your gut goes quiet on day two and three, week after week, you stop seeing a run of bad luck and start seeing a shape. A bad day feels like something you caused. A pattern is just how your body handles this drug.

The same screen carries the estimated level of the drug in your body, from a one compartment model using the published half-lives. It is an educational estimate, not a measurement of your blood. The free curve calculator at setva.app/glp-1-calculator runs the same math in your browser, with no signup.

Setva is not on the App Store yet. Join the waitlist and be first when it launches, at 79.99 USD a year or 12.99 USD a week, with no trial. Your logs live on your iPhone and in your own private iCloud: no account, no login, no server of ours.

Be first when it launches Try the free curve calculator

Setva is coming to the App Store. Join the waitlist and you will hear from us once, the day it goes live.

The bottom line

Constipation on a GLP-1 is common, expected and mechanical. Roughly one in four people on semaglutide 2.4 mg reported it in the trials, against about one in nine on placebo. It clusters early and after each dose increase. You are not doing this wrong.

Water before fiber, a walk after meals, smaller plates, and a pharmacist for anything you buy.

The line to remember: no stool and no gas, a belly that stays swollen, vomiting that will not stop, pain that will not settle. That is a phone call tonight, not a search result. And nothing here is a reason to change your dose on your own.

Questions people ask

How long does GLP-1 constipation usually last?

The labels do not give a number. They say gastrointestinal reactions are most frequently reported during dose escalation and decrease over time, so the first weeks and the weeks after each increase are where most people feel it.

Does it get better if I stay on the medication?

Often, at least partly. A 2024 review in The Journal of Clinical Endocrinology and Metabolism reports that with sustained exposure to the long acting GLP-1 receptor agonists, the effect on gastric emptying weakens over time, though some slowing stays.

Is constipation worse on a specific day after my shot?

There is no published day by day pattern. Drug level does rise after each injection and decline across the week, but whether your hard days land early or late in that cycle is something only your own log will show.

Can constipation from a GLP-1 become dangerous?

It is uncommon, but the Ozempic, Wegovy and Zepbound labels all list ileus, intestinal obstruction and severe constipation including fecal impaction under postmarketing reports. The practical version is the red flag list above.

Do the daily pills cause it too?

Yes, because the mechanism is the same slowing of gastric emptying and gut transit. With a daily oral there is no weekly rise and fall, so symptoms track the titration step rather than the day of the week.

Will my prescriber lower my dose because of this?

That is their call and it depends on your history. There are usually things they try before touching the dose, and you should never adjust, skip or split anything on your own. Bring them details: how many days, and whether gas, pain or vomiting are involved.

Sources

This is an educational estimate based on published half-life data, not a measurement of your blood. Never change your dose without your prescriber.

The Setva Team

Setva is built by a small team that reads the label, the FDA prescribing information and the published pharmacokinetics, and then writes what they found. We are not clinicians and we do not employ any. Every number on this site links to the primary source it came from, so you can check it yourself, and everything here is educational. Your prescriber knows your case, we do not.